Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.37 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.33 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.33 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20823292 | 1.00 | PDK2 (0.37) | PDK2FTOMEN1MAPTKMT2A | |
| SCHEMBL20824492 | 0.95 | PDK2 (0.35) | PDK2FTOMEN1MAPTKMT2A | |
| SCHEMBL20822748 | 0.95 | PDK2 (0.35) | PDK2FTOMEN1MAPTKMT2A | |
| SCHEMBL24622507 | 0.95 | PDK2 (0.38) | PDK2FTOMEN1MAPTKMT2A | |
| SCHEMBL20824090 | 0.95 | PDK2 (0.35) | PDK2FTOMEN1MAPTKMT2A | |
| SCHEMBL24646468 | 0.95 | PDK2 (0.38) | PDK2FTOMEN1MAPTKMT2A | |
| SCHEMBL20823271 | 0.95 | PDK2 (0.38) | PDK2FTOMEN1MAPTKMT2A | |
| SCHEMBL20822689 | 0.95 | PDK2 (0.35) | PDK2FTOMEN1MAPTKMT2A | |
| SCHEMBL24027695 | 0.93 | PDK2 (0.36) | PDK2FTOMEN1MAPTKMT2A | |
| SCHEMBL20823368 | 0.93 | MEN1 (0.38) | PDK2FTOMEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3663288-B1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO (JP) | 2022-06-08 | — | — | EP | disclosed |
| EP-3663288-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | Idemitsu Kosan Co., Ltd (JP) | 2020-06-10 | — | — | EP | disclosed |
| US-10424740-B2 | Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2019-09-24 | — | — | US | disclosed |
| US-20190088879-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2019-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190088879-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE | PIEZO1, LEF1, L1CAM | PDK2 2623/4885FTO 468/4885MEN1 633/4885 |
| US-10424740-B2 | Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic device | PIEZO1, LEF1, L1CAM | PDK2 2623/4885FTO 468/4885MEN1 633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.